LHC Group Inc(LHCG) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy, a family health center, a rural health clinic, and a retail pharmacy, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to Accountable Care Organizations. As of December 31, 2019, it operated 553 home health services locations, 110 hospice locations, 107 community-based service locations, 11 long-term acute care hospitals with 13 locations, and 10 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.

Current Price

$201.32

RSI

33.528

Beta:

0.379481

February 26, 2021
286.6M
27.8M
58.9M

0.191 %
-2.503 %
70.249 %
14.901 %

$2,063,204,000
$2,080,241,000
$1,809,963,000
$1,072,086,000
$914,823,000
$816,366,000
-0.826 %
14.933 %
68.826 %
17.191 %
12.060 %

$173,976,000
$140,459,000
$101,322,000
$71,330,000
$68,118,000
$64,498,000
23.862 %
38.626 %
42.047 %
4.715 %
5.613 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.